JPH05502889A - 新規アデノシン誘導体、その製造および使用法 - Google Patents

新規アデノシン誘導体、その製造および使用法

Info

Publication number
JPH05502889A
JPH05502889A JP3513113A JP51311391A JPH05502889A JP H05502889 A JPH05502889 A JP H05502889A JP 3513113 A JP3513113 A JP 3513113A JP 51311391 A JP51311391 A JP 51311391A JP H05502889 A JPH05502889 A JP H05502889A
Authority
JP
Japan
Prior art keywords
desoxy
ethylamide
acid
ester
carbonic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP3513113A
Other languages
English (en)
Japanese (ja)
Inventor
ガディエント、フルビオ
Original Assignee
サンド・リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by サンド・リミテッド filed Critical サンド・リミテッド
Publication of JPH05502889A publication Critical patent/JPH05502889A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
JP3513113A 1990-08-16 1991-08-13 新規アデノシン誘導体、その製造および使用法 Pending JPH05502889A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4025879A DE4025879A1 (de) 1990-08-16 1990-08-16 Neue adenosin derivate, deren herstellung und verwendung
DE4025879.3 1990-08-16

Publications (1)

Publication Number Publication Date
JPH05502889A true JPH05502889A (ja) 1993-05-20

Family

ID=6412310

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3513113A Pending JPH05502889A (ja) 1990-08-16 1991-08-13 新規アデノシン誘導体、その製造および使用法

Country Status (11)

Country Link
EP (1) EP0496852A1 (enExample)
JP (1) JPH05502889A (enExample)
AU (1) AU638600B2 (enExample)
CA (1) CA2064869A1 (enExample)
CS (1) CS97892A3 (enExample)
DE (1) DE4025879A1 (enExample)
FI (1) FI921691A0 (enExample)
HU (1) HUT60504A (enExample)
PL (1) PL294368A1 (enExample)
TW (1) TW197448B (enExample)
WO (1) WO1992003463A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994007904A1 (en) * 1992-10-01 1994-04-14 Mcneilab, Inc. Derivatives of 7,8-disubstituted guanosines
GB9301000D0 (en) * 1993-01-20 1993-03-10 Glaxo Group Ltd Chemical compounds
CN114437159B (zh) * 2022-04-11 2022-06-28 佛山市晨康生物科技有限公司 一种环状碳酸酯核苷类化合物及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4167565A (en) * 1976-11-08 1979-09-11 Abbott Laboratories Adenosine-5'-carboxamides and method of use
US4514405A (en) * 1981-09-17 1985-04-30 Merck Patent Gesellschaft Mit Beschrankter Haftung Use of adenosine derivatives as anticonvulsants
DE3406533A1 (de) * 1984-02-23 1985-08-29 Boehringer Mannheim Gmbh, 6800 Mannheim Verwendung von adenosin-derivaten als antiallergica und arzneimittel, die diese enthalten
AU579412B2 (en) * 1984-10-26 1988-11-24 Warner-Lambert Company N` - substituted adenosines

Also Published As

Publication number Publication date
PL294368A1 (en) 1993-06-28
FI921691A7 (fi) 1992-04-15
FI921691A0 (fi) 1992-04-15
HU9201080D0 (en) 1992-06-29
CA2064869A1 (en) 1992-02-17
CS97892A3 (en) 1992-08-12
DE4025879A1 (de) 1992-02-20
HUT60504A (en) 1992-09-28
AU8303291A (en) 1992-03-17
AU638600B2 (en) 1993-07-01
WO1992003463A1 (de) 1992-03-05
TW197448B (enExample) 1993-01-01
EP0496852A1 (de) 1992-08-05

Similar Documents

Publication Publication Date Title
KR100837420B1 (ko) 5-히드록시-인돌-3-카르복시산에스테르 유도체 및 이의용도
KR100359676B1 (ko) 벤조일구아니딘및이의제조방법
CZ284456B6 (cs) Aminosubstituované benzoylguanidiny, způsob jejich přípravy, jejich použití jako léčiv a léčivo, které je obsahuje
NZ274848A (en) 2-n-amidinocarbamoyl-3-aminopiperazine derivatives substituted by a phenyl substituted piperazinyl moiety
EP0037778A1 (fr) Benzodioxanne 1,4 méthoxy-2 propanolamines, leur préparation et leur application en tant que médicaments
FR2623806A1 (fr) Esters d'acides 3,6-dihydro-1,5(2h)-pyrimidinecarboxyliques a action therapeutique
JP3539926B2 (ja) 抗ウイルス性ピリミジンジオン誘導体及びそれらの製造方法
WO2021030472A1 (en) Nanoparticle compositions
US4505921A (en) Sulfonylurea compounds and their use in treating diabetes
JPS611685A (ja) ジヒドロピリジン類
BRPI1007902B1 (pt) Compostos de fenilmidazol
BE1003632A3 (fr) Nouveaux derives de l'adenosine, leur preparation et leur utilisation comme medicaments.
EP1265871B1 (en) Pyridazinyl phenyl hydrazones useful against congestive heart failure
JPH05502889A (ja) 新規アデノシン誘導体、その製造および使用法
PT78491B (en) Process for the preparation of new 5-acyl-2-(1h)-pyridinones useful as cardiotonic agents
KR980008230A (ko) 쇼크 상태의 치료 및 예방을 위한 테오필린 유도체의 용도, 크산틴 화합물 및 이의 제조방법
US6004966A (en) Use of xanthine oxidase inhibitors as anti-ischaemic agents
EP0430025A2 (en) Xanthine compound, method for preparing thereof, and a pharmaceutical composition comprising the same
CN1051298C (zh) 取代的环己醇酯、其治疗疾病的用途和药物制剂
US4980351A (en) 3-aminopropoxyaryl derivatives having cardiotonic and antihypertensive use and compositions thereof
CN116655510B (zh) 一种四氢吡咯烷类化合物及其制备方法和应用
EP0395526A1 (fr) Nouveaux dérivés benzothiazolinoniques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
US4678796A (en) 2-alkylidene derivatives of 1,2,3,4-tetrahydropyridine-2,5-pyridine carboxylic acid dialkyl esters useful for treatment of cardiovascular disorders
WO2005026167A1 (en) Process for preparing famciclovir
JPS603391B2 (ja) 新規ピリミジン化合物の製法